The global market for Automated and Rapid Microbiological Tests is estimated at US$6.3 Billion in 2023 and is projected to reach US$10.0 Billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the automated and rapid microbiological tests market is driven by several factors. The rising prevalence of infectious diseases and the growing need for prompt and accurate diagnostics have significantly increased the demand for rapid testing solutions. In the healthcare sector, the emphasis on reducing hospital-acquired infections and improving patient outcomes has led to the widespread adoption of automated microbiological testing systems. The pharmaceutical and biotechnology industries also rely heavily on these tests for ensuring the sterility and quality of products, driven by stringent regulatory requirements. Additionally, the food and beverage industry uses rapid microbiological tests to ensure safety and compliance with health standards. Technological advancements, such as the miniaturization of devices and the development of user-friendly interfaces, have made these tests more accessible to a broader range of users. Government initiatives and funding aimed at improving public health infrastructure and response capabilities further support market growth. These factors, combined with continuous innovations in diagnostic technologies, are propelling the expansion of the automated and rapid microbiological tests market.
The growth in the automated and rapid microbiological tests market is driven by several factors. The rising prevalence of infectious diseases and the growing need for prompt and accurate diagnostics have significantly increased the demand for rapid testing solutions. In the healthcare sector, the emphasis on reducing hospital-acquired infections and improving patient outcomes has led to the widespread adoption of automated microbiological testing systems. The pharmaceutical and biotechnology industries also rely heavily on these tests for ensuring the sterility and quality of products, driven by stringent regulatory requirements. Additionally, the food and beverage industry uses rapid microbiological tests to ensure safety and compliance with health standards. Technological advancements, such as the miniaturization of devices and the development of user-friendly interfaces, have made these tests more accessible to a broader range of users. Government initiatives and funding aimed at improving public health infrastructure and response capabilities further support market growth. These factors, combined with continuous innovations in diagnostic technologies, are propelling the expansion of the automated and rapid microbiological tests market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the GC/CRT (Clinical) Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8.0%. The AISS (Clinical) Application segment is also set to grow at 3.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.4 Billion in 2023, and China, forecasted to grow at an impressive 9.3% CAGR to reach $1.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Automated and Rapid Microbiological Tests Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Automated and Rapid Microbiological Tests Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Automated and Rapid Microbiological Tests Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 3M Company, Abbott Laboratories, Inc., Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 77 Featured):
- 3M Company
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Abbott Molecular, Inc.
- American Type Culture Collection (ATCC)
- Biocartis NV
- Biomerica, Inc.
- AutoGenomics, Inc.
- BioControl Systems, Inc.
- BioFire Diagnostics LLC
- BIT Analytical Instruments GmbH
- Biosystems S.A.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- 3M Company
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Abbott Molecular, Inc.
- American Type Culture Collection (ATCC)
- Biocartis NV
- Biomerica, Inc.
- AutoGenomics, Inc.
- BioControl Systems, Inc.
- BioFire Diagnostics LLC
- BIT Analytical Instruments GmbH
- Biosystems S.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 489 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.3 Billion |
| Forecasted Market Value ( USD | $ 10 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
